SEC ownership of Genprex, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001595248.

Comparable stake leader

INTRACOASTAL CAPITAL, LLC

Disclosed value leader

J. Rodney Varner

Comparable rows

32/37

Latest evidence

14 Apr 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
32 of 37
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
INTRACOASTAL CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
14 Apr 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001595248
Issuer location
Austin, TX

Ownership snapshot

Top shareholders of Genprex, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
J. Rodney Varner
Comparable rows
32/37
Latest evidence
14 Apr 2026
13D/G 3/4/5 13F Lead comparable stake: 5% 5 rows are not safely comparable across share classes. 13D/G row: INTRACOASTAL CAPITAL, LLC Showing 1-8 of 37 holder rows.

Quick read

INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 5%.

32 of 37 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership Top 5
INTRACOASTAL CAPITAL, LLC 5%
Ayrton Capital LLC 2.7%
Forsakringsaktiebolaget Avanza Pe... 0.02%
Ryan M. Confer 0.39%
Mark Stanley Berger 0.23%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 37 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
84,814 shares
$0 28 Oct 2025
Ayrton Capital LLC
13D/G
2.7%
$302,243
249,788 shares
$0 31 Mar 2026
Forsakringsaktiebolaget Avanza Pension
13D/G
0.02%
$1,732
5,974 shares
$0 31 Dec 2024
Ryan M. Confer
3/4/5
President, CEO and CFO, Director
0.39%
$72,662
36,331 shares
27 Feb 2026
Mark Stanley Berger
3/4/5
Chief Medical Officer
0.23%
$43,384
21,692 shares
27 Feb 2026
Brent M. Longnecker
3/4/5
Director
0.1%
$11,263
9,157 shares
-$22 14 Apr 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.36%
$60,403
33,372 shares
31 Mar 2026
MANCHESTER FINANCIAL INC
13F
Company
13F
0.22%
$36,200
20,000 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$22.14.

Buys
$0
Insiders: 0
Sells
$22.14
Insiders: 1
Net
-$22.14
Shares: -18
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 18
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 18 $0 $22.14 -$22.14
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-8 of 8 reporting-owner rows connected to Genprex, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
8
Largest Forms 3/4/5 holder
J. Rodney Varner
Net 12M change
-$22
Latest report
14 Apr 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
J. Rodney Varner Chairman, President and CEO, Director $1,245,464 Mixed 18 Feb 2024
Catherine M. Vaczy EVP GC Chief Strategy Officer $279,575 Filing P/S 21 Apr 2023
Hermant Kumar Chief Mfgr & Tech Officer $211,000 Mixed 18 Feb 2023
Ryan M. Confer President, CEO and CFO, Director $72,662 Mixed 27 Feb 2026
Mark Stanley Berger Chief Medical Officer $43,384 Mixed 27 Feb 2026
Brent M. Longnecker Director $11,263 -$22 -0.19% Filing P/S 14 Apr 2026
Jose Antonio Moreno Toscano Director $4,395 Market 22 Dec 2025
William R. Wilson Jr. Director $4,395 Market 22 Dec 2025

Recent insider transactions for Genprex, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Brent M. Longnecker GNPX Common Stock Sale -100% $12.3 $1.23 -10 0 14 Apr 2026 By: Longnecker Associates Ltd
Brent M. Longnecker GNPX Common Stock Sale -0.09% $9.84 $1.23 -8 9,157 14 Apr 2026 Direct
Mark Stanley Berger GNPX Common Stock Tax liability -24.8% -7,168 21,692 27 Feb 2026 Direct
Ryan M. Confer GNPX Common Stock Tax liability -20.4% -9,330 36,331 27 Feb 2026 Direct
Jose Antonio Moreno Toscano GNPX Common Stock Award 5732.5% 9,000 9,157 22 Dec 2025 Direct
Mark Stanley Berger GNPX Common Stock Award 7916.7% 28,500 28,860 22 Dec 2025 Direct
Ryan M. Confer GNPX Common Stock Award 6807.9% 45,000 45,661 22 Dec 2025 Direct
Brent M. Longnecker GNPX Common Stock Award 5454.6% 9,000 9,165 22 Dec 2025 Direct
William R. Wilson Jr. GNPX Common Stock Award 5732.5% 9,000 9,157 22 Dec 2025 Direct
Mark Stanley Berger GNPX Common Stock Tax liability -20% -4,500 17,971 30 Jun 2025 Direct
Ryan M. Confer GNPX Common Stock Tax liability -14.9% -5,775 32,968 30 Jun 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .